JPS6133819B2 - - Google Patents
Info
- Publication number
- JPS6133819B2 JPS6133819B2 JP5722276A JP5722276A JPS6133819B2 JP S6133819 B2 JPS6133819 B2 JP S6133819B2 JP 5722276 A JP5722276 A JP 5722276A JP 5722276 A JP5722276 A JP 5722276A JP S6133819 B2 JPS6133819 B2 JP S6133819B2
- Authority
- JP
- Japan
- Prior art keywords
- caprolactam
- amino
- chloroform
- adduct
- crystals
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 87
- BOWUOGIPSRVRSJ-UHFFFAOYSA-N 2-aminohexano-6-lactam Chemical compound NC1CCCCNC1=O BOWUOGIPSRVRSJ-UHFFFAOYSA-N 0.000 claims description 43
- 238000000034 method Methods 0.000 claims description 16
- 238000002425 crystallisation Methods 0.000 claims description 2
- 230000008025 crystallization Effects 0.000 claims description 2
- 238000000926 separation method Methods 0.000 claims description 2
- 239000013078 crystal Substances 0.000 description 22
- JBKVHLHDHHXQEQ-UHFFFAOYSA-N epsilon-caprolactam Chemical compound O=C1CCCCCN1 JBKVHLHDHHXQEQ-UHFFFAOYSA-N 0.000 description 12
- 238000004817 gas chromatography Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 239000000203 mixture Substances 0.000 description 5
- CHPSWOWDEYXTFU-UHFFFAOYSA-N n-(2-aminocyclohexylidene)hydroxylamine Chemical compound NC1CCCCC1=NO CHPSWOWDEYXTFU-UHFFFAOYSA-N 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 239000012535 impurity Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 238000006237 Beckmann rearrangement reaction Methods 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000008707 rearrangement Effects 0.000 description 2
- 238000006462 rearrangement reaction Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Description
【発明の詳細な説明】
本発明はα−アミノ−ε−カプロラクタムの精
製方法に関するものである。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for purifying α-amino-ε-caprolactam.
α−アミノ−ε−カプロラクタムは必須アミノ
酸であるリジンや他の化合物の有用な合成原料で
あることは知られているが、このα−アミノ−ε
−カプロラクタムをリジンの合成原料とする場合
には特に高純度のα−アミノ−ε−カプロラクタ
ムが要求される。本発明者らはかかる要求にもと
ずいて、極めて高純度のα−アミノ−ε−カプロ
ラクタムを取得する方法がないか否かを鋭意検討
した結果、α−アミノ−ε−カプロラクタムとク
ロロホルムとの間に他の溶剤にみられない特異な
挙動、すなわちα−アミノ−ε−カプロラクタム
1分子とクロロホルム1分子とが単離可能な結晶
状付加物を生成し、さらに該付加物からクロロホ
ルムを分離除去することも容易であるという事実
を見い出し、これを利用してα−アミノ−ε−カ
プロラクタムを高純度に精製するという本発明を
なすに至つた。 α-Amino-ε-caprolactam is known to be a useful raw material for the synthesis of the essential amino acid lysine and other compounds;
- When caprolactam is used as a raw material for lysine synthesis, particularly highly purified α-amino-ε-caprolactam is required. Based on this request, the inventors of the present invention conducted extensive studies to determine whether there is a method for obtaining extremely high purity α-amino-ε-caprolactam, and found that During this process, a unique behavior not seen in other solvents occurs, in which one molecule of α-amino-ε-caprolactam and one molecule of chloroform form an isolable crystalline adduct, and chloroform is further separated and removed from the adduct. The present inventors have discovered that it is easy to purify α-amino-ε-caprolactam, and have utilized this fact to accomplish the present invention, which purifies α-amino-ε-caprolactam to a high degree of purity.
従つて、本発明の目的は、粗α−アミノ−ε−
カプロラクタム中の不純物の除去を効果的に行な
い。高純度α−アミノ−ε−カプロラクタムを得
ることのできる新規な精製方法を確立することに
ある。 Therefore, the object of the present invention is to obtain crude α-amino-ε-
Effectively removes impurities in caprolactam. The object of the present invention is to establish a new purification method capable of obtaining highly pure α-amino-ε-caprolactam.
この目的は、粗α−アミノ−ε−カプロラクタ
ムとクロロホルムと接触させた後、晶析分離する
ことによりα−アミノ−ε−カプロラクタムとク
ロロホルムとの結晶状付加物を単離し、次いで該
付加物からクロロホルムを分離除去するという手
段を採用することによつて達成される。 The purpose was to isolate the crystalline adduct of α-amino-ε-caprolactam and chloroform by contacting the crude α-amino-ε-caprolactam with chloroform and then to separate it by crystallization, and then to isolate the crystalline adduct of α-amino-ε-caprolactam and chloroform from the adduct. This is achieved by separating and removing chloroform.
以下具体的に本発明の方法を詳述する。 The method of the present invention will be specifically described below.
本発明において使用される粗α−アミノ−ε−
カプロラクタムはいかなる方法で取得したもので
もよい。またいかなる工程で取得されたものでも
よい。したがつて2−アミノシクロヘキサノンオ
キシムをベツクマン転位して得た反応混合物、そ
れを中和して得た反応混合物、またはそれらをな
かば精製して得たα−アミノ−ε−カプロラクタ
ムなどを使用し得る。これにクロロホルムを添加
してα−アミノ−ε−カプロラクタムと接触させ
る。この接触の際、α−アミノ−ε−カプロラク
タムは遊離の形で存在することが必要である。 Crude α-amino-ε- used in the present invention
Caprolactam may be obtained by any method. Moreover, it may be obtained by any process. Therefore, a reaction mixture obtained by Beckman rearrangement of 2-aminocyclohexanone oxime, a reaction mixture obtained by neutralizing it, or α-amino-ε-caprolactam obtained by semi-purifying them, etc. can be used. . Chloroform is added to this and brought into contact with α-amino-ε-caprolactam. During this contact, it is necessary that the α-amino-ε-caprolactam be present in free form.
従つて、粗α−アミノ−ε−カプロラクタムと
してベツクマン転位して得た反応混合物を用いる
場合は、α−アミノ−ε−カプロラクタムの遊離
の形にするためにアンモニア等のアルカリで中和
する必要がある。この場合のクロロホルムの量は
組成物中に含まれる成分の種類や成分比さらに操
作温度に応じて任意に決められるが結晶状のα−
アミノ−ε−カプロラクタムとクロロホルムの付
加物を系外に分離する段階においては、少なくと
も組成物中のα−アミノ−ε−カプロラクタムに
対して1〜3倍モル量で操作するのが好ましい。 Therefore, when using the reaction mixture obtained by Beckmann rearrangement as crude α-amino-ε-caprolactam, it is necessary to neutralize it with an alkali such as ammonia in order to convert it into a free form of α-amino-ε-caprolactam. be. The amount of chloroform in this case can be arbitrarily determined depending on the types and component ratios of the components contained in the composition, as well as the operating temperature.
In the step of separating the adduct of amino-ε-caprolactam and chloroform out of the system, it is preferable to use the adduct in an amount of at least 1 to 3 times the molar amount of α-amino-ε-caprolactam in the composition.
組成物からのα−アミノ−ε−カプロラクタム
とクロロホルムとの付加物を生成させる場合の温
度は0℃からクロロホルムの沸点に至る範囲の温
度である。また生成した結晶状の付加物を系外に
分離する場合の温度は付加物の物性から30℃以下
の温度で操作することが必要である。 The temperature for producing the adduct of α-amino-ε-caprolactam and chloroform from the composition ranges from 0° C. to the boiling point of chloroform. Furthermore, when separating the formed crystalline adduct out of the system, it is necessary to operate at a temperature of 30° C. or lower due to the physical properties of the adduct.
付加物を生成させる場合のα−アミノ−ε−カ
プロラクタムとクロロホルムとの接触時間は前記
温度範囲において15分以上の時間があれば十分で
ある。 When producing an adduct, a contact time of 15 minutes or more between α-amino-ε-caprolactam and chloroform in the above temperature range is sufficient.
次にかくして得られた結晶状のα−アミノ−ε
−カプロラクタムとクロロホルムの付加物をα−
アミノ−ε−カプロラクタムとクロロホルムとに
分離する。この場合分離する方法は特に限定され
るものではなく、例えば付加物を常温で高真空系
におくことにより、クロロホルムを揮散させる方
法、あるいはα−アミノ−ε−カプロラクタムの
溶解性が小さく、かつクロロホルムを溶解し易い
溶剤と接触させてクロロホルムを溶出除去する方
法、また逆の水のようなα−アミノ−ε−カプロ
ラクタムに対する溶解性が大でクロロホルムを溶
解しにくい溶剤でα−アミノ−ε−カプロラクタ
ムを溶解分離する方法など多くの方法が適用で
き、付加物の性状からいずれの場合も室温で操作
が可能であり、α−アミノ−ε−カプロラクタム
が不純化しない条件を選ぶことができる。 Next, the thus obtained crystalline α-amino-ε
−Adduct of caprolactam and chloroform α−
Separate into amino-ε-caprolactam and chloroform. In this case, the separation method is not particularly limited; for example, a method in which the adduct is placed in a high vacuum system at room temperature to volatilize chloroform, or a method in which α-amino-ε-caprolactam has low solubility and chloroform A method for eluting and removing chloroform by contacting it with a solvent that easily dissolves chloroform, and a method for eluting and removing chloroform by contacting it with a solvent that easily dissolves α-amino-ε-caprolactam. Many methods can be applied, such as a method of dissolving and separating .alpha.-amino-.epsilon.-caprolactam, and in any case, the operation can be performed at room temperature depending on the properties of the adduct, and conditions can be selected that will not impure α-amino-ε-caprolactam.
このように本発明法では不純物と共存する系か
ら選択的にα−アミノ−ε−カプロラクタムとク
ロロホルムの付加物結晶体を形成させ、該付加物
の分離において不純物はクロロホルム中に溶解し
たまま付加物と分離されるのでα−アミノ−ε−
カプロラクタムの高純度化が進み、さらに付加物
からクロロホルムを除く工程で完全にα−アミノ
−ε−カプロラクタムが精製される。 In this way, in the method of the present invention, an adduct crystal of α-amino-ε-caprolactam and chloroform is selectively formed from a system coexisting with impurities, and when the adduct is separated, the impurity remains dissolved in chloroform. α-amino-ε-
Caprolactam is highly purified, and α-amino-ε-caprolactam is completely purified in the step of removing chloroform from the adduct.
以下実施例をもつて本発明の効果を証明する。 The effects of the present invention will be demonstrated below using Examples.
実施例 1
α−アミノ−ε−カプロラクタム12.8g(0.10
モル)を含む2−アミノシクロヘキサノンオキシ
ムのベツクマン転位反応物42.0gを15%アンモニ
ア水でPH=8.0に調整し、この液とクロロホルム
35.7g(0.3モル)とを、かきまぜ機、還流冷却
器、温度計を備えた200ml容ガラス製3つ口フラ
スコに仕込んだ、湯浴で内液を加熱し、温度を40
℃に保ちながら15分間かきまぜた後、内液の全量
を分液漏斗に移し、クロロホルム層を分取した。Example 1 α-Amino-ε-caprolactam 12.8g (0.10g
42.0 g of a Beckman rearrangement reaction product of 2-aminocyclohexanone oxime containing
35.7 g (0.3 mol) was placed in a 200 ml three-necked glass flask equipped with a stirrer, reflux condenser, and thermometer.The inner solution was heated in a hot water bath to bring the temperature to 40
After stirring for 15 minutes while maintaining the temperature at °C, the entire volume of the internal solution was transferred to a separating funnel, and the chloroform layer was separated.
分取したクロロホルム層から20.0gのクロロホ
ルムが系内に残るようにクロロホルムを揮散さ
せ、再び上記3つ口フラスコに移し、かきまぜな
がら40℃から5℃に徐冷すると結晶が析出した。
全液について遠心分離機を用い結晶19.4gを分離
採取した。 Chloroform was evaporated from the separated chloroform layer so that 20.0 g of chloroform remained in the system, and the mixture was again transferred to the three-necked flask and slowly cooled from 40° C. to 5° C. while stirring to precipitate crystals.
19.4 g of crystals were separated and collected from the entire solution using a centrifuge.
この結晶は融点31℃を示し、ガスクロマトグラ
フイで分析すると、α−アミノ−ε−カプロラク
タム51.6重量%、クロロホルム48.4重量%であ
り、α−アミノ−ε−カプロラクタム:クロロホ
ルム(モル比)=1:1.01であつた。 This crystal has a melting point of 31°C, and when analyzed by gas chromatography, it is found to be 51.6% by weight of α-amino-ε-caprolactam and 48.4% by weight of chloroform, α-amino-ε-caprolactam:chloroform (molar ratio) = 1: It was 1.01.
採取した結晶のうち15.0gを25℃で10mmHgの
減圧下でクロロホルムを揮散させると7.7gの白
色結晶が得られた。この結晶のガスクロマトグラ
フイによるα−アミノ−ε−カプロラクタムの分
析値は99.7重量%であつた。 Chloroform was evaporated from 15.0 g of the collected crystals at 25° C. under a reduced pressure of 10 mmHg, yielding 7.7 g of white crystals. The α-amino-ε-caprolactam analysis value of this crystal by gas chromatography was 99.7% by weight.
実施例 2
α−アミノ−ε−カプロラクタム12.8g(0.1
モル)を含む2−アミノシクロヘキサノンオキシ
ムのベツクマン転位反応物を実施例1と同じ操作
方法でPHを9.0に調整し、クロロホルム35.7g
(0.3モル)を実施例1の3つ口フラスコに移し、
内蔵を40℃にして15分間かきまぜた後クロロホル
ム層を分取した。このクロロホルム層の一部をか
きまぜ機と温度計および滴下漏斗とクロロホルム
留去用冷却器を備えた100ml容ガラス製4つ口フ
ラスコに仕込み内蔵をかきまぜながら液温を冷水
浴で10℃に維持した。残りのクロロホルム層を滴
下漏斗から滴下させながら冷却器を通して内部を
減圧にし、内液の組成がα−アミノ−ε−カプロ
ラクタム1モルに対しクロロホルム1.8モルの比
になるようにクロロホルムを留去させると結晶が
析出した。全量を取り出し、遠心分離器で分離し
た結晶量は19.2gであり、ガスクロマトグラフイ
で分析したα−アミノ−ε−カプロラクタムは
51.6重量%、クロロホルム48.4重量%であつた。Example 2 α-amino-ε-caprolactam 12.8g (0.1
The pH of the Beckman rearrangement product of 2-aminocyclohexanone oxime containing (mol) was adjusted to 9.0 using the same procedure as in Example 1, and 35.7 g of chloroform
(0.3 mol) was transferred to the three-necked flask of Example 1,
After heating the internal organs to 40°C and stirring for 15 minutes, the chloroform layer was separated. A portion of this chloroform layer was placed in a 100 ml glass four-necked flask equipped with a stirrer, a thermometer, a dropping funnel, and a condenser for chloroform distillation, and the liquid temperature was maintained at 10°C in a cold water bath while stirring the contents. . While dropping the remaining chloroform layer from the dropping funnel, the inside was reduced in pressure through a condenser, and the chloroform was distilled off so that the composition of the internal solution was 1.8 moles of chloroform to 1 mole of α-amino-ε-caprolactam. Crystals precipitated. The total amount of crystals was taken out and separated using a centrifuge, and the amount of crystals was 19.2 g. The amount of α-amino-ε-caprolactam analyzed by gas chromatography was
51.6% by weight, and 48.4% by weight of chloroform.
採取した結晶のうち15.0gをシクロヘキサン50
ml中に投入しよくかきまぜた後、結晶と溶剤を分
離し、7.7gの結晶を得た。この結晶をガスクロ
マトグラフイで分析するとα−アミノ−ε−カプ
ロラクタムの純度99.6重量%であつた。 15.0g of the collected crystals was added to 50% of cyclohexane.
After stirring well, the crystals and the solvent were separated to obtain 7.7 g of crystals. Analysis of the crystals by gas chromatography revealed that the purity of α-amino-ε-caprolactam was 99.6% by weight.
実施例 3
2−アミノシクロヘキサノンオキシムのベツク
マン転位反応に関連する有機副生不純物を含み、
純度78重量%のアルカリ性粗α−アミノ−ε−カ
プロラクタム16.4g(α−アミノ−ε−カプロラ
クタム0.10モル)とクロロホルム17.8g(0.15モ
ル)を実施例1の3つ口フラスコに仕込み、冷水
浴で10℃に保ちながら30分間かきまぜると結晶が
析出した。全量を取り出し遠心分離器を用いて分
離した結晶は16.7gでこの結晶をガスクロマトグ
ラフイで分析するとα−アミノ−ε−カプロラク
タム51.5重量%、クロロホルム48.5重量%であつ
た。Example 3 Contains organic by-product impurities related to the Beckmann rearrangement reaction of 2-aminocyclohexanone oxime,
16.4 g (0.10 mol) of alkaline crude α-amino-ε-caprolactam with a purity of 78% by weight and 17.8 g (0.15 mol) of chloroform were placed in the three-necked flask of Example 1, and heated in a cold water bath. When stirred for 30 minutes while maintaining the temperature at 10°C, crystals precipitated. The total amount was taken out and separated using a centrifuge. 16.7 g of crystals were analyzed by gas chromatography and found to be 51.5% by weight of α-amino-ε-caprolactam and 48.5% by weight of chloroform.
分離した結晶のうち15gに水15mlを加えると2
層に分液した。水の層を分取して減圧乾燥により
水分を除去し7.7gの結晶を得た。この結晶をガ
スクロマトグラフイで分析するとα−アミノ−ε
−カプロラクタムは99.9重量%であつた。 When 15 ml of water is added to 15 g of the separated crystals, 2
It was separated into layers. The water layer was separated and the water was removed by drying under reduced pressure to obtain 7.7 g of crystals. When this crystal was analyzed by gas chromatography, α-amino-ε
- Caprolactam was 99.9% by weight.
実施例 4
2−アミノシクロヘキサノンオキシムのベツク
マン転位反応により合成した粗α−アミノ−ε−
カプロラクタムを減圧蒸留して精製した純度97.8
%のα−アミノ−ε−カプロラクタム13.1g(α
−アミノ−ε−カプロラクタム0.10モル)とクロ
ロホルム15.5g(0.13モル)を実施例1の3つ口
フラスコに仕込み、少量のアンモニアガスを吹き
込んでから室温で30分間かきまぜた。全量をビー
カに移し、氷水の浴で5℃に冷却すると結晶が析
出した。採取した結晶のうち15.0gを25℃で10mm
Hgの減圧下でクロロホルムを揮発させると7.7g
の白色結晶が得られた。この精製α−アミノ−ε
−カプロラクタムの純度は99.7%であつた。Example 4 Crude α-amino-ε- synthesized by Beckman rearrangement reaction of 2-aminocyclohexanone oxime
Purity 97.8 purified by vacuum distillation of caprolactam
% α-amino-ε-caprolactam 13.1 g (α
-amino-ε-caprolactam (0.10 mol) and chloroform (15.5 g (0.13 mol)) were placed in the three-necked flask of Example 1, a small amount of ammonia gas was blown into the flask, and the flask was stirred at room temperature for 30 minutes. The entire amount was transferred to a beaker and cooled to 5°C in an ice water bath to precipitate crystals. 15.0g of the collected crystals were heated to 10mm at 25°C.
When chloroform is evaporated under reduced pressure of Hg, 7.7g
White crystals were obtained. This purified α-amino-ε
- The purity of caprolactam was 99.7%.
Claims (1)
ホルムとを接触させた後、晶析分離することによ
りα−アミノ−ε−カプロラクタムとクロロホル
ムとの結晶状付加物を単離し、次いで該付加物か
らクロロホルムを分離除去することを特徴とする
α−アミノ−ε−カプロラクタムの精製方法。1. After bringing crude α-amino-ε-caprolactam into contact with chloroform, a crystalline adduct of α-amino-ε-caprolactam and chloroform is isolated by crystallization separation, and then chloroform is removed from the adduct. A method for purifying α-amino-ε-caprolactam, which comprises separating and removing it.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5722276A JPS52142087A (en) | 1976-05-20 | 1976-05-20 | Purification of alpha-amino-epsilon-caprolactam |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5722276A JPS52142087A (en) | 1976-05-20 | 1976-05-20 | Purification of alpha-amino-epsilon-caprolactam |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS52142087A JPS52142087A (en) | 1977-11-26 |
JPS6133819B2 true JPS6133819B2 (en) | 1986-08-04 |
Family
ID=13049490
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP5722276A Granted JPS52142087A (en) | 1976-05-20 | 1976-05-20 | Purification of alpha-amino-epsilon-caprolactam |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS52142087A (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0680750U (en) * | 1992-04-28 | 1994-11-15 | 村田機械株式会社 | Paper feeder for facsimile machine |
-
1976
- 1976-05-20 JP JP5722276A patent/JPS52142087A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS52142087A (en) | 1977-11-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO314500B1 (en) | Process for Preparation of 4-Acetoxy-2 <alpha> - benzoyloxy-5 <beta>, 20-epoxy-1,7 <beta>, 10 <beta> tri-hydroxy-9-oxo-tax-11-en-13 < alpha> -yl (2R, 3S) -3-tert-butoxycarbonylamino-2-hydroxy-3-phenylpropionate trihydrate | |
JP2008516005A (en) | Improved preparation of letrozole | |
IL31704A (en) | Process for the preparation of the dextrorotatory 2,2'-(ethylenediimino)-di-1-butanol | |
JPS6133819B2 (en) | ||
JP2008521804A (en) | Method for crystallizing benzphetamine | |
WO2023104022A1 (en) | Method for preparing monosubstituted alkynylthiacalix[4]arene | |
US20080207896A1 (en) | Process For the Manufacture of Mirtazapine | |
CA1055046A (en) | Preparation of .epsilon.(.gamma.glutamyl)-lysine | |
JPH10500941A (en) | Purification of amidocarboxylic acid | |
US4467119A (en) | Phenolic antioxidant | |
US5091540A (en) | Process for preparing clotrimazole | |
JPS6133820B2 (en) | ||
CN108911951A (en) | A kind of thymol and preparation method thereof and pharmaceutical composition | |
JPS6026103B2 (en) | Method for recovering ε-caprolactam and ammonium sulfate | |
JPS61251662A (en) | Purification of pyridine | |
JPH0446253B2 (en) | ||
KR860001900B1 (en) | A process for preparing-chloroalanine | |
JP2010105935A (en) | METHOD FOR PURIFYING 4-(8-CHLORO-5,6-DIHYDRO-11H-BENZO[5,6]CYCLOHEPTA[1,2-b]PYRIDIN-11-YLIDENE)-1-PIPERIDINECARBOXYLIC ACID ETHYL ESTER | |
SU968030A1 (en) | Process for purifying 2-mercaptopropylamine or its hydrochloride | |
JP2708552B2 (en) | Purification method of aliphatic triamine compound | |
US2708198A (en) | Pentaerythrite-dichlorhydrine monosulfurous acid esters | |
JP2002020370A (en) | Method for removing hydrogen chloride from mixture containing n-alkyl-2-pyrrolidone and hydrogen chloride | |
JPH0210134B2 (en) | ||
SU410627A1 (en) | Method for simultaneous production of hydroxylamine chloride and adipic acid | |
JPH10109991A (en) | Production of dimethylamine-borane |